|
|
| Research article summary (published 30 Jan 2003): |
Neurotransmission of cognition, part 2. Selective NRIs are smart drugs: exploiting regionally selective actions on both dopamine and norepinephrine to enhance cognition.
Full Abstract
ISSUE:
Selective norepinephrine reuptake inhibitors such as atomoxetine increase both dopamine and norepinephrine in frontal cortex and may thereby enhance cognitive functioning in attention-deficit/hyperactivity disorder.
Learn Faster Today Improve your study skills
Author information
Author/s: Stahl, Stephen M (SM);
Affiliation: Neuroscience Education Institute, Carlsbad, Calif 92009, USA.
Journal and publication information
Publication Type: Journal Article
Journal: The Journal of clinical psychiatry (J Clin Psychiatry), published in United States. (Language: eng)
Reference: 2003-Feb; vol 64 (issue 2) : pp 110-1
Dates: Created 2003/03/13; Completed 2003/03/26; Revised 2005/11/17;
PMID: 12633117, status: MEDLINE (last retrieval date: 11/6/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
This article has not been indexed for related articles as yet, however you can still use the live related article search links below.
See a large map of 100+ related articles.